Table 3. Functional characterisation of Ca2+-binding protein genes altered expressed in OSCC-derived cell lines.
Relevant function and disease | P-value | Gene, noa |
---|---|---|
Top-10 functions associated with upregulated genes in OSCC-derived cell lines | ||
Cancerb | 1.15E−3 to 4.27E−2 | 7 |
Cell death | 1.15E−3 to 6.42E−2 | 4 |
Cell cycle | 1.86E−3 to 6.95E−2 | 6 |
Cell-to-cell signalling and interaction | 3.94E−3 to 6.16E−2 | 7 |
Cell signalling | 3.29E−3 to 6.42E−2 | 6 |
Molecular transport | 4.29E−3 to 7.47E−2 | 5 |
Small molecule biochemistry | 4.29E−3 to 7.47E−2 | 9 |
Nucleic acid metabolism | 5.07E−3 to 2.89E−2 | 4 |
Cellular growth and proliferation | 5.07E−3 to 6.95E−2 | 3 |
Cell morphology | 8.24E−3 to 6.95E−2 | 1 |
Top-10 functions associated with downregulated genes in OSCC-derived cell lines | ||
Cellular movementc | 1.60E−13 to 8.53E−3 | 33 |
Cellular signalling | 1.52E−11 to 8.53E−3 | 31 |
Cellular function and maintenance | 1.52E−11 to 8.53E−3 | 16 |
Small molecule biochemistry | 1.52E−11 to 8.53E−3 | 20 |
Vitamin and mineral metabolism | 1.52E−11 to 7.02E−3 | 32 |
Tissue morphology | 2.10E−11 to 8.53E−3 | 33 |
Molecular transport | 2.69E−11 to 8.53E−3 | 18 |
Skeletal and vascular system development and function | 2.08E−10 to 8.53E−3 | 21 |
Cancer | 5.13E−9 to 8.53E−3 | 27 |
Cell-to-cell signalling and interaction | 1.01E−8 to 8.53E−3 | 26 |
Number of associated genes.
Apoptosis, cell movement, proliferation, cell cycle progression, migration, binding quantity of cancer cell line.
Chemotaxis, migration, cell movement, mobilisation of haematologic cyte.